Clinical Trial: Clinical Trial to Evaluate the Safety, Pharmacokinetic Characteristics of DW5124 and DW5124-R, and the Effect of Food on DW5124 in Healthy Adult Volunteers

U.S., Jan. 7 -- ClinicalTrials.gov registry received information related to the study (NCT07319559) titled 'Clinical Trial to Evaluate the Safety, Pharmacokinetic Characteristics of DW5124 and DW5124-R, and the Effect of Food on DW5124 in Healthy Adult Volunteers' on Dec. 22, 2025.

Brief Summary: This study aimed to evaluate the safety and pharmacokinetic characteristics of DW5124 and DW5124-R, and the effect of food on DW5124, in healthy adult volunteers.

Study Start Date: May 08, 2025

Study Type: INTERVENTIONAL

Condition: Mixed Dyslipidemia

Intervention: DRUG: DW5124

DW5124 on fasted or fed condition

DRUG: DW5124-R

DW5124-R on fasted or fed condition

Recruitment Status: COMPLETED

Sponsor: Daewon Pharmaceutical Co., Ltd.

Discl...